Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Revolution Medicines (RVMD) Other Gross PP&E Adjustments (2019 - 2025)

Revolution Medicines has reported Other Gross PP&E Adjustments over the past 7 years, most recently at -$103.8 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at -$103.8 million for Q4 2025, down 13.31% from a year ago — trailing twelve months through Dec 2025 was -$103.8 million (down 13.31% YoY), and the annual figure for FY2025 was -$103.8 million, down 13.31%.
  • Other Gross PP&E Adjustments for Q4 2025 was -$103.8 million at Revolution Medicines, down from -$76.9 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for RVMD hit a ceiling of $8.4 million in Q1 2023 and a floor of -$103.8 million in Q4 2025.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$31.2 million (2024), compared with a mean of -$37.5 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 124.02% in 2023 and later crashed 524.42% in 2024.
  • Revolution Medicines' Other Gross PP&E Adjustments stood at -$41.2 million in 2021, then grew by 29.57% to -$29.0 million in 2022, then plummeted by 60.26% to -$46.5 million in 2023, then crashed by 97.23% to -$91.6 million in 2024, then decreased by 13.31% to -$103.8 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were -$103.8 million (Q4 2025), -$76.9 million (Q3 2025), and -$58.8 million (Q2 2025) per Business Quant data.